PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15722572-2	2005	The purpose of this study was to compare the prevalence of K-ras and c-erbB-2 mutations in PA and CP in order to evaluate their usefulness in differential diagnosis of those diseases.	Protactinium	91-93	erb-b2 receptor tyrosine kinase 2	Homo sapiens	69-77	
15722572-6	2005	Prevalence of c-erbB-2 amplification in patients with PA was 17 (65.3%), which was not different from CP, 16 (56.5%) (p=0.58).	Protactinium	54-56	erb-b2 receptor tyrosine kinase 2	Homo sapiens	14-22